Monitoring minimal residual disease in patients with multiple myeloma by targeted tracking serum M-protein using mass spectrometry (EasyM).

EasyM is a highly sensitive and minimal invasive method of MRD monitoring in MM, MS-MRD had significant predictive ability for survival outcomes.